ArticleJournal of gastrointestinal cancer2025
Melanoma and Colorectal Cancer as Second Primary Cancers: A Scoping Review of Their Association and the Underlying Biological, Lifestyle, and Genetic Factors.
Article in Journal of gastrointestinal cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeSecond primary cancers (SPCs) are independent primary cancers that develop separately from pre-existing malignancies, distinct from metastasis or recurrence. This study aims to review the current literature and analyse the association between melanoma and colorectal cancer (CRC), as well as the factors contributing to the development of these SPCs.
methodsA scoping review was conducted, including 21 independent studies. Patient data from these studies were analysed and reviewed alongside relevant biological and lifestyle factors.
resultsThe studies reported standardised incidence ratios (SIRs) for a second primary colorectal cancer (CRC) following a melanoma diagnosis ranging from 0.62 to 1.55, while SIRs for a second primary melanoma following a CRC diagnosis ranged from 0.89 to 1.55. Males exhibited a higher risk of developing either CRC or melanoma as a second primary cancer (SPC). An inverse relationship between age and the development of CRC was observed, with younger individuals having a higher risk. African-American populations demonstrated a higher prevalence of melanoma and CRC as SPCs compared to Caucasian and other racial groups. Lifestyle factors such as alcohol consumption, sun exposure, and the intake of red and processed meats were associated with an increased risk of developing melanoma or CRC. Genetic mutations in KRAS, NRAS, and BRAF were commonly implicated in the development of both melanoma and CRC, while mutations in CDKN2A and BRCA2 were specifically significant in melanoma.
conclusionThe association between melanoma and CRC incidence was confirmed through analysis of current literature and is influenced by various biological, lifestyle, and genetic factors. Understanding these correlations is crucial for predicting the risk of SPCs and enhancing the follow-up care of melanoma and CRC survivors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.